Celltrion financial statements

셀트리온KRX:068270 · KOSPI · Healthcare · sector #23
₩180,000-1.91%
2026-10-08 close

Celltrion's published financial data is dated 2026-10-04. 2024 revenue was KRW 3.56T. 2024 operating profit was KRW 502.53B.

Reported results

Financial safety

Reference indicatorAs of 2024
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 6.55
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
6.55
Beneish M-Score
-2.40

No statistical flag

Sloan accrual
-2.28%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

5/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score5/9

Profitability

  • Positive ROAPass
  • Positive OCFPass
  • Improving ΔROANot passed
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesPass

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverPass

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Margin trendWarning

영업이익률 악화 (29.7% → 14.1%, -15.6%p). 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
14.1%
Interest coverage
5.2x
Return on equity (ROE)
2.4%

Operating margin −5pp

Tolerable
Interest coverageBase 5.2x adverse case 3.4x
Return on equity (ROE)Base 2.4% adverse case 1.3%

Revenue −15%

Tolerable
Interest coverageBase 5.2x adverse case 4.4x
Return on equity (ROE)Base 2.4% adverse case 1.9%

Interest rate +2pp

Tolerable
Interest coverageBase 5.2x adverse case 3x
Return on equity (ROE)Base 2.4% adverse case 1.9%

Interest coverage limit

Current margin 11.4pp

Interest coverage limit at an operating margin of 2.7%

Interest expense coverage threshold

Celltrion notifications

Quantus Signal · live data · not investment advice · Privacy Policy